[Development toward segmental and focal hyalinosis of a nephrotic syndrome with minimal glomerular lesions in a patient treated with sulindac].
Pagniez
D
D
Gosset
D
D
Hardouin
P
P
Noël
C
C
Delvallez
L
L
Dequiedt
P
P
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006818:Hyalin / Q000378:metabolism; D007192:Indenes / Q000009:adverse effects*; D009402:Nephrosis, Lipoid / Q000139:chemically induced* / Q000378:metabolism; D013467:Sulindac / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007192:Indenes; D013467:Sulindac
Evolution vers la hyalinose segmentaire et focale d'un syndrome néphrotique à lésions glomérulaires minimes chez une patiente traitée par le sulindac.